Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a 17.187\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) COc1cc(/C=N/NC(=O)C(C)Nc2n[nH]c(=O)[nH]c2=O)ccc1O
b.) CCc1ccc(NC(=O)c2cc(S(=O)(=O)N3CCc4ccccc43)cn2C)cc1
c.) Cc1cc(C)cc(N(CC(=O)NC2CCCC2)C(=O)C2(C)CC(=O)N=C3C=CC=CN32)c1
Answer: c. Cc1cc(C)cc(N(CC(=O)NC2CCCC2)C(=O)C2(C)CC(=O)N=C3C=CC=CN32)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(C)cc(N(CC(=O)NC2CCCC2)C(=O)C2(C)CC(=O)N=C3C=CC=CN32)c1
Cc1cc(C)cc(N(CC(=O)NC2CCCC2)C(=O)C2(C)CC(=O)N=C3C=CC=CN32)c1
N-[2-(cyclopentylamino)-2-oxoethyl]-N-(3,5-dimethylphenyl)-4-methyl-2-oxo-3H-pyrido[1,2-a]pyrimidine-4-carboxamide